B cells

Armadillo girdled lizard biting its own tail in a defensive pose
Biotech

Ouro launches with $120M and a clinical-stage T-cell engager

Ouro's lead asset comes from Chinese biotech Keymed Biosciences, which is currently testing the drug in a phase 2 trial in multiple myeloma.
Darren Incorvaia Jan 10, 2025 6:00am
An artists concept of T cells attacking a cancer cell The T cells are in red while the cancer is light blue The cells are

SNAP, CAR-M and BiTE: New immunotherapy approaches at SITC

Nov 6, 2023 11:36am
cancer cell surrounded by killer T cells

Novel cancer vaccines look beyond T cells to better fight tumors

May 27, 2022 2:00pm
Nkarta Offices

Nkarta touts a double dose of data for natural killer therapies

Apr 25, 2022 11:55am
Joanne Smith-Farrell

Be Bio closes Arch Venture-led $130M financing round

Apr 14, 2022 10:45am
A group of executives work together to solve a puzzle

Takeda inks another biobucks pact: $900M for Immusoft's B cells

Oct 13, 2021 8:00am